Alpha-2 Agonist — Analgesic Adjunct / Sedation
Pregnancy: Use with caution — crosses placenta; neonatal bradycardia reported
Clonidine
Brand names: Catapres, Duraclon (epidural)
Adult dose
Dose: Epidural adjunct: 75-150 micrograms. IV adjunct: 1-3 micrograms/kg slowly. Oral: 50-200 micrograms three times daily
Route: Oral / IV / Epidural / Peripheral nerve block adjunct
Frequency: As needed (IV/epidural); three times daily (oral)
Max: Epidural: 150 micrograms; IV perioperative: 3 micrograms/kg
As local anaesthetic adjunct (epidural/nerve block): prolongs block duration and improves analgesia quality. Perineural clonidine 75-150 micrograms extends peripheral nerve block by 2-4 hours
Paediatric dose
Dose: 1-2 micrograms/kg IV (sedation adjunct); 1-2 micrograms/kg caudal adjunct micrograms/kg
Route: IV / Caudal / Oral
Frequency: Single dose (IV/caudal); two to three times daily (oral)
Max: 150 micrograms (caudal)
Caudal adjunct: 1-2 micrograms/kg added to local anaesthetic extends caudal block duration by 2-4 hours
Dose adjustments
Renal
Reduce dose in renal impairment — primarily renally excreted
Hepatic
No significant adjustment required
Paediatric weight-based calculator
Caudal adjunct: 1-2 micrograms/kg added to local anaesthetic extends caudal block duration by 2-4 hours
Clinical pearls
- Perineural clonidine as local anaesthetic adjunct: alpha-2 receptors on peripheral nerves mediate analgesia; 75-150 micrograms added to peripheral nerve block solution extends duration by 2-4 hours — well-established in regional anaesthesia
- Clonidine in paediatric caudal anaesthesia: 1-2 micrograms/kg significantly extends caudal block duration — used routinely in paediatric regional anaesthesia to reduce post-operative analgesic requirements
- Opioid-sparing: reduces anaesthetic and opioid requirements intraoperatively by 25-40% — central alpha-2 agonism attenuates nociception
- Rebound hypertension: abrupt withdrawal after chronic oral use causes hypertensive crisis — always taper; use patch formulation for reliable delivery in perioperative period
- Dexmedetomidine (highly selective alpha-2 agonist) is now preferred over clonidine for IV sedation — higher alpha-2:alpha-1 selectivity ratio means more predictable sedation with less vasoconstriction
Contraindications
- Severe bradycardia or heart block (without pacemaker)
- Sick sinus syndrome
- Rebound hypertension risk (abrupt withdrawal after chronic use)
Side effects
- Bradycardia and hypotension
- Sedation
- Dry mouth
- Rebound hypertension on abrupt withdrawal (chronic use)
- Dizziness
Interactions
- Beta-blockers (severe bradycardia — additive)
- Antihypertensives (enhanced hypotension)
- TCAs (reduce clonidine antihypertensive effect)
- CNS depressants (additive sedation)
Monitoring
- Heart rate (bradycardia)
- Blood pressure
- Sedation level
- Block duration (if used as adjunct)
Reference: BNFc; BNF 90; Catapres SPC; PROSPECT Clonidine Review; Eisenach et al. (perineural clonidine); AAGBI. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Richmond Agitation-Sedation Scale (RASS) · Sedation Assessment
- Confusion Assessment Method for ICU (CAM-ICU) · Delirium Assessment
- Ramsay Sedation Scale · Sedation
- Ramsay Sedation Scale · Sedation Assessment
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Faecal Peritonitis · ASGBI; RCS — Best Practice
- Acute Compartment Syndrome · BAPRAS; BOA; RCS — Best Practice